Jim Simons's position in Rigel Pharmaceuticals is currently worth $7.48M. That's 0.01% of their equity portfolio (1157th largest holding). The first Rigel Pharmaceuticals trade was made in Q2 2013. Since then Jim Simons bought shares 28 more times and sold shares on nineteen occasions. The stake costed the investor $3.23M, netting the investor a gain of 132% so far.